7 results
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
considered (doses and duration ... same as for treatment ... Note: Treatment ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
in HIV-AIDS Preventing ... CMV Disease: ... CMV end-organ disease ... ., concomitant medications ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
Indications: ... confirmation of disease ... vaccination results in disease ... times daily (BII) Duration ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Recommendations for Preventing ... Prophylaxis): Indications ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
) Indications: ... Preferred Therapy (Duration ... #LTBI #Mycobacterium ... Tuberculosis #TB #IDSA #Prevention ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS
Early Stage (Primary, Secondary,
(Syphilis) to Prevent ... Latent of Unknown Duration ... pallidum #IDSA #Prevention ... #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
in HIV-AIDS Indications ... Severe Disseminated Disease ... IV daily (AI) Duration ... #Treatment #management ... #HIVAIDS #pharmacology